Gene · 8317
Papers1,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional analysis of the stable phosphoproteome reveals cancer vulnerabilities. | Bioinformatics | 2022 | 35015814 | PubTator, text mining | PubMed |
| Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma. | Int J Biol Sci | 2022 | 34975331 | PubTator, text mining | PubMed |
| Structural mechanism for the selective phosphorylation of DNA-loaded MCM double hexamers by the Dbf4-dependent kinase. | Nat Struct Mol Biol | 2022 | 34963704 | PubTator, text mining | PubMed |
| Chiffon triggers global histone H3 acetylation and expression of developmental genes in Drosophila embryos. | J Cell Sci | 2022 | 34908116 | PubTator, text mining | PubMed |
| Integrated genome and tissue engineering enables screening of cancer vulnerabilities in physiologically relevant perfusable ex vivo cultures. | Biomaterials | 2022 | 34890975 | PubTator, text mining | PubMed |
| Transcriptome and Exome Analyses of Hepatocellular Carcinoma Reveal Patterns to Predict Cancer Recurrence in Liver Transplant Patients. | Hepatol Commun | 2022 | 34725972 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Kinase Inhibitor, in Patients With Advanced Solid Tumors. | J Clin Pharmacol | 2022 | 34564871 | PubTator, text mining | PubMed |
| Critical DNA damaging pathways in tumorigenesis. | Semin Cancer Biol | 2022 | 33905873 | PubTator, text mining | PubMed |
| Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells. | Cell Biol Toxicol | 2022 | 33884520 | PubTator, text mining | PubMed |
| Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. | Explor Target Antitumor Ther | 2021 | 36046090 | PubTator, text mining | PubMed |
| The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. | Front Oncol | 2021 | 35145908 | PubTator, text mining | PubMed |
| LncRNA-miRNA-mRNA Networks of Gastrointestinal Cancers Representing Common and Specific LncRNAs and mRNAs. | Front Genet | 2021 | 35140741 | PubTator, text mining | PubMed |
| Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis. | Transl Cancer Res | 2021 | 35116413 | PubTator, text mining | PubMed |
| Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer. | Cell Rep Med | 2021 | 35028612 | PubTator, text mining | PubMed |
| Potential biomarkers and signaling pathways associated with the pathogenesis of primary salivary gland carcinoma: a bioinformatics study. | Genomics Inform | 2021 | 35012286 | PubTator, text mining | PubMed |
| An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma. | Front Mol Biosci | 2021 | 34970594 | PubTator, text mining | PubMed |
| Identification of MCM4 as a Prognostic Marker of Hepatocellular Carcinoma. | Biomed Res Int | 2021 | 34961841 | PubTator, text mining | PubMed |
| Ikaros Proteins in Tumor: Current Perspectives and New Developments. | Front Mol Biosci | 2021 | 34950704 | PubTator, text mining | PubMed |
| New Candidates for Autism/Intellectual Disability Identified by Whole-Exome Sequencing. | Int J Mol Sci | 2021 | 34948243 | PubTator, text mining | PubMed |
| Transcriptome Analysis in Vulvar Squamous Cell Cancer. | Cancers (Basel) | 2021 | 34944992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8317/papers?page=19